CureSearch combats the loss of promising scientists from the field by providing significant financial support to investigators early in their research career. Early-career investigators are the most vulnerable to federal funding shortages, and they rely more than ever on the support of private foundations like CureSearch in order to continue their research.
These grants are limited to truly transformational science designed to deliver the next generation of cancer treatment. Starting in 2012, CureSearch supported 12 Young Investigators for two years in research areas with high risk and poor outcomes: relapsed ALL, AML, brain tumors, Ewing sarcoma, hepatoblastoma, Hodgkin disease, neuroblastoma, non-Hodgkin lymphoma, rhabdomyosarcoma, survivorship/late effects, adolescent and young adult cancer, and Wilms tumor. Encouraged by this success, CureSearch awarded six new grants in 2015 for 3 years with more than double the funds, allowing more young researchers to establish a sustainable model from the outset of their research. Now, in 2018, CureSearch has wrapped up the six grants and is soon announcing two new grants for 2018 to conclude in 2021.